DTBN
Pulsar + sobre un periodo para mostrar cada año
The role of antileukotrienes in children
Pharmacological management of type 2 diabetes. A pending solution
The Vascular Risk Study in Navarra (RIVANA). Applications in clinical practice
Magical numbers in pharmacological prevention of cardiovascular disease and fractures. A critical appraisal
Bisphosphonates: Do they prevent or cause bone fractures?
The interpretation of the results of a randomised controlled trial
Secondary prevention of cardiovascular disease with statins. How far should we go?
Prehospital management of trauma patients
Pharmacological treatment of obesity
Non-steroidal anti-inflammatory drugs and cardiovascular risk
Statins in primary prevention of cardiovascular disease: Is use based on real evidence or distorted evidence?
Rosiglitazone and pioglitazone: A Critical Appraisal of the PROactive and DREAM trials
New drug evaluation. The experience of the Spanish Mixed Committee on New Drugs Assessment (MCNDA)
Treatment of urinary incontinence in elderly patients
Insulin treatment in type 2 diabetes
Aspectos legales y prácticos de la nutrición enteral domiciliaria
Estudio "LIFE" (Losartan vs Atenolol): Revisión bibliográfica y evaluación crítica
Manejo del paciente con EPOC en el Ámbito de Atención Primaria
Nuevos AINE: Inhibidores de la COX-2
Tratamiento psicofarmacológico de los síntomas psicológicos y conductuales de la demencia